JP2010538252A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010538252A5 JP2010538252A5 JP2010522447A JP2010522447A JP2010538252A5 JP 2010538252 A5 JP2010538252 A5 JP 2010538252A5 JP 2010522447 A JP2010522447 A JP 2010522447A JP 2010522447 A JP2010522447 A JP 2010522447A JP 2010538252 A5 JP2010538252 A5 JP 2010538252A5
- Authority
- JP
- Japan
- Prior art keywords
- sample
- identification method
- cypa
- identifying
- cyclophilin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0716804.0A GB0716804D0 (en) | 2007-08-29 | 2007-08-29 | Identifying organ damage |
| PCT/GB2008/002947 WO2009027703A2 (en) | 2007-08-29 | 2008-08-29 | Identifying organ damage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010538252A JP2010538252A (ja) | 2010-12-09 |
| JP2010538252A5 true JP2010538252A5 (enExample) | 2011-10-13 |
Family
ID=38616940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010522447A Pending JP2010538252A (ja) | 2007-08-29 | 2008-08-29 | 器官損傷の同定方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8110371B2 (enExample) |
| EP (1) | EP2183601A2 (enExample) |
| JP (1) | JP2010538252A (enExample) |
| GB (1) | GB0716804D0 (enExample) |
| WO (1) | WO2009027703A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2743211A1 (en) | 2008-11-12 | 2010-05-20 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Methods and systems of using exosomes for determining phenotypes |
| US20120116817A1 (en) * | 2009-07-01 | 2012-05-10 | Chantal Boulanger | Methods for Predicting Cardiovascular Mortality Risk |
| US9128101B2 (en) | 2010-03-01 | 2015-09-08 | Caris Life Sciences Switzerland Holdings Gmbh | Biomarkers for theranostics |
| WO2011127219A1 (en) | 2010-04-06 | 2011-10-13 | Caris Life Sciences Luxembourg Holdings | Circulating biomarkers for disease |
| ITNA20110012A1 (it) * | 2011-03-14 | 2012-09-15 | Amal Raj Delfin Albert | Procedura di isolamento e di purificazione degli esosomi urinari per la ricerca di biomarcatori proteici |
| CN105606811A (zh) * | 2016-02-01 | 2016-05-25 | 中南大学 | 一种鼻咽癌诊断试剂盒 |
| JP7444386B2 (ja) * | 2018-06-07 | 2024-03-06 | 株式会社Ｌｓｉメディエンス | ヒト尿からのマイクロベシクルの分離方法及び分析方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4436352A1 (de) * | 1994-10-12 | 1996-04-18 | Kay Brune | Verfahren zur diagnostischen Beurteilung und Verlaufskontrolle sowie Arzneimittel zur Therapie von Schockzuständen beim Menschen |
| US6719969B1 (en) * | 1999-08-09 | 2004-04-13 | The Regents Of The University Of Michigan | Treatment of liver disease and injury with CXC chemokines |
| AU2002216273A1 (en) * | 2000-12-29 | 2002-07-16 | Oxford Glycosciences (Uk) Limited | Proteins, genes and their use for diagnosis and treatment of kidney response |
| US7469185B2 (en) * | 2002-02-04 | 2008-12-23 | Ocimum Biosolutions, Inc. | Primary rat hepatocyte toxicity modeling |
| WO2007127848A1 (en) * | 2006-04-26 | 2007-11-08 | University Of Louisville Research Foundation, Inc | Isolation of membrane vesicles from biological fluids and methods of using same |
-
2007
- 2007-08-29 GB GBGB0716804.0A patent/GB0716804D0/en not_active Ceased
-
2008
- 2008-08-29 WO PCT/GB2008/002947 patent/WO2009027703A2/en not_active Ceased
- 2008-08-29 US US12/675,479 patent/US8110371B2/en not_active Expired - Fee Related
- 2008-08-29 EP EP08788492A patent/EP2183601A2/en not_active Withdrawn
- 2008-08-29 JP JP2010522447A patent/JP2010538252A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sathyanarayan et al. | Elevated level of interleukin‐6 predicts organ failure and severe disease in patients with acute pancreatitis | |
| Bureau et al. | Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease | |
| Esmat et al. | Role of Helicobacter pylori in patients with HCV‐related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: possible association with disease progression | |
| Simoneau et al. | The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial | |
| Lin et al. | Epidemiology of cancer | |
| Sikander et al. | Association of serotonin transporter promoter polymorphism (5-HTTLPR) with microscopic colitis and ulcerative colitis | |
| WO2007011412A3 (en) | Diagnosis and prognosis of infectious diesease clinical phenotypes and other physiologic states using host gene expresion biomarkers in blood | |
| JP2013515270A5 (enExample) | ||
| Archimandritis et al. | Rapid urease test is less sensitive than histology in diagnosing Helicobacter pylori infection in patients with non‐variceal upper gastrointestinal bleeding | |
| JP2017505897A5 (enExample) | ||
| Kasperska‐Zając et al. | Acute phase inflammatory markers in patients with non‐steroidal anti‐inflammatory drugs (NSAIDs)‐induced acute urticaria/angioedema and after aspirin challenge | |
| Smith et al. | YAP1 withdrawal in hepatoblastoma drives therapeutic differentiation of tumor cells to functional hepatocyte‐like cells | |
| Oleksowicz et al. | Secretory phospholipase A2‐IIa is a target gene of the HER/HER2‐elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer | |
| Shin et al. | Overexpression of C-reactive protein as a poor prognostic marker of resectable hepatocellular carcinomas | |
| US20120016002A1 (en) | Patient Selection and Therapeutic Methods Using Markers of Prostaglandin Metabolism | |
| Yang et al. | Soluble E‐cadherin is associated with oxidative stress in patients with chronic HBV infection | |
| Chen et al. | The production and comparative evaluation of native and recombinant antigens for the fast serodiagnosis of cystic echinococcosis with dot immunogold filtration assay | |
| Kucur et al. | Extended high frequency audiometry in polycystic ovary syndrome | |
| Kuo et al. | Quantitative proteomic analysis of differentially expressed protein profiles involved in pancreatic ductal adenocarcinoma | |
| Feng et al. | Novel urinary protein panels for the non‐invasive diagnosis of non‐alcoholic fatty liver disease and fibrosis stages | |
| Cazzagon et al. | Rise and fall of HCV‐related hepatocellular carcinoma in Italy: a long‐term survey from the ITA. LI. CA centres | |
| Schmid et al. | The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: Which markers matter and how should they be used? | |
| Wang et al. | ABHD17C represses apoptosis and pyroptosis in hepatocellular carcinoma cells | |
| Cai et al. | Adenoviral transduction of Dickkopf-1 alleviates silica-induced silicosis development in lungs of mice | |
| Ishiguro et al. | Coexpression of aPKCλ/ι and IL‐6 in prostate cancer tissue correlates with biochemical recurrence |